Come up with a name for your new list and we'll add to it:
VirxSys raised a round of funding on December 22, 2011. Investors include
OSV Currency Advisors.
VIRxSYS is a privately-held biotechnology company with proprietary platform technologies with which the Company intends to develop therapies for serious human diseases. The Company's platform technolo…